Prodrugs of proton pump inhibitors including the (1h-pyrrol-1-yl)-1h-benzimidazole moiety
申请人:Garst Michael E.
公开号:US20100113524A1
公开(公告)日:2010-05-06
The compounds of the formulas (I), (II), (III) and (IV), where the symbols are as defined in the specification are prodrugs of proton pump inhibitors. The R
4
group includes at least one acidic group or its pharmaceutically acceptable salt, and the compound having the R
4
group have improved aqueous solubility, stability in plasma and improved bioavailability.
公式(I)、(II)、(III)和(IV)的化合物,其中符号如规范中定义的那样,是质子泵抑制剂的前药。R4基团包括至少一个酸性基团或其药学上可接受的盐,具有R4基团的化合物具有改善的水溶性、血浆稳定性和改善的生物利用度。